Celldex Therapeutics

Celldex Therapeutics

Biotechnology, Perryville III Building 53 Frontage Rd Ste 220, Hampton, New Jersey, 08827, United States, 51-200 Employees

celldex.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +19*********

Who is CELLDEX THERAPEUTICS

Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequ...

Read More

map
  • Perryville III Building 53 Frontage Rd Ste 220, Hampton, New Jersey, 08827, United States Headquarters: Perryville III Building 53 Frontage Rd Ste 220, Hampton, New Jersey, 08827, United States
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Million to $5 Million
  • Anthony Marucci CEO:   Anthony Marucci

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from CELLDEX THERAPEUTICS

Celldex Therapeutics Org Chart and Mapping

Employees

Morgan Hays

Manufacturing Associate-Purification

Karen Tavares

Quality Assurance Specialist II

Karyssa Edwards

Analytical Development Supervisor

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Celldex Therapeutics

Answer: Celldex Therapeutics's headquarters are located at Perryville III Building 53 Frontage Rd Ste 220, Hampton, New Jersey, 08827, United States

Answer: Celldex Therapeutics's phone number is +19*********

Answer: Celldex Therapeutics's official website is https://celldex.com

Answer: Celldex Therapeutics's revenue is $1 Million to $5 Million

Answer: Celldex Therapeutics's SIC: 2834

Answer: Celldex Therapeutics has 51-200 employees

Answer: Celldex Therapeutics is in Biotechnology

Answer: Celldex Therapeutics contact info: Phone number: +19********* Website: https://celldex.com

Answer: Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access